Organigram Holdings | OGI - Gewinn Vor Steuern

Aktienkurs
1.93
Täglich Wechseln
0.02 1.05%
Monatlich
-1.53%
Jährlich
41.91%
Q2 Prognose
1.87




Gewinn Vor Steuern Veränderung Datum
Acasti Pharma USD -2.31M 1.38M 2025-12
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alaunos Therapeutics USD -7.84M 633K 2023-12
Aurora Cannabis CAD -1.58M 48.55M 2025-12
Avita Medical AUD -11.64M 12.13M 2025-12
Canopy Growth CAD -62.26M 60.84M 2025-12
Cronos Group USD 31.78M 70.78M 2025-09
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Ionis Pharmaceuticals USD -228M 99M 2025-12
IQVIA Holdings USD 6.16B 5.84B 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Moderna USD -187M 631M 2025-09
Organigram Holdings CAD -41.72M 25.52M 2025-09
Organon & Co USD 243M 14M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Tectonic Therapeutic USD -18.97M 63K 2025-12
Tilray USD -39.96M 39.19M 2025-09
Viatris USD -7.9M 209.2M 2025-09
Xeris Pharmaceuticals USD 11.08M 10.46M 2025-12